首页> 中文期刊> 《中国民康医学》 >急性心肌梗死早期合并恶性室性心律失常患者的临床分析

急性心肌梗死早期合并恶性室性心律失常患者的临床分析

         

摘要

目的::探讨急性心肌梗死早期合并恶性室性心律失常患者的发病机制及治疗效果。方法:选取69例急性心肌梗死早期合并恶性室性心律失常患者,依据心电图分为Ι组31例(单纯下壁心肌梗死)、Ⅱ组30例(下壁并发前壁心肌梗死)、Ⅲ组8例(下壁、正后壁并右室心肌梗死);均用胺碘酮治疗,观察与分析3组患者的治疗效果。结果:Ι组患者心力衰竭发生率显著低于Ⅱ组、Ⅲ组(P<0.05)。结论:下壁、正后壁合并右室急性心肌梗死患者死亡率较高,要密切观察其症状、体征,降低并发症发生率,有效改善其预后。%Objective: To explore pathogenesis and treatment effects of patients with early acute myocardial infarction com-bined with malignant ventricular arrhythmia. Methods:69 cases with early acute myocardial infarction combined with malignant ven-tricular arrhythmia were divided into group I (31 cases, pure inferior wall myocardial infarction), group II (30 cases, inferior compli-cated with anterior wall myocardial infarctions), and group III (8 cases, inferior wall, posterior wall and right ventricular myocardial infarctions) according to ECG results. All the patients were given Amiodarone treatment, and the treatment effects of the three groups were observed and analyzed. Results:The incidence of heart failure of group I was significantly lower than those of group II and III ( P<0. 05). Conclusions:The patients with inferior wall, posterior wall and right ventricular myocardial infarctions have a higher mortali-ty, therefore, their symptoms and signs should be closely observed in order to reduce the incidence of complications and improve the prognosis.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号